Methods for treating systemic lupus erythematosus with an anti-apolipoprotein B antibody
US10434141B2 · kind B2 · utility
2Cited by
42References
5Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | May 31, 2017 |
| Grant date | Oct 8, 2019 |
| Priority date | — |
| Expiry date | May 31, 2037 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY02A50/30
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Described herein are peptides and antibodies for prevention and/or therapeutic treatment of mammals, including humans, against systemic lupus erythematosus, as well as diagnosing the presence or absence of antibodies related to increased or decreased risk of developing SLE and/or to disease grading, staging, and/or prognosis.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.